Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 33094 [E8-13043]
Download as PDF
<![CDATA[
33094
Federal Register / Vol. 73, No. 113 / Wednesday, June 11, 2008 / Notices
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than June 26,
2008.
A. Federal Reserve Bank of Kansas
City (Todd Offenbacker, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Peter Joseph Fiene and Jane
Frances Fiene, both of Overland Park,
Kansas, and the Patrick Robert Fiene
Family Irrevocable Trust No. 1, Peter
Joseph Fiene, trustee, to acquire voting
shares of BOR Bancorp, and thereby
indirectly acquire voting shares of Bank
of Rothville, both in Rothville, Missouri.
Board of Governors of the Federal Reserve
System, June 6, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–13032 Filed 6–10–08; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
sroberts on PROD1PC70 with NOTICES
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Board Meeting Times and Dates (All times
are Central Daylight Time):
9 a.m.–5 p.m., June 24, 2008.
9 a.m.–5 p.m., June 25, 2008.
9 a.m.–2 p.m., June 26, 2008.
VerDate Aug<31>2005
16:13 Jun 10, 2008
Jkt 214001
Public Comment Times and Dates (All
times are Central Daylight Time):
5 p.m.–6 p.m., June 24, 2008.
7:30 p.m.–8:30 p.m., June 25, 2008.
Place: Millennium Hotel St. Louis, 200
South 4th Street, St. Louis, MO 63102,
Telephone (314) 241–9500, Fax (314) 516–
6149.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 75 to 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2009.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The agenda for the
Advisory Board meeting includes: NIOSH
Program Status Update; Special Exposure
Cohort (SEC) Petitions for: Y–12 Plant, Dow
Chemical Company, and Spencer Chemical
Company; SEC Petition Updates: Chapman
Valve, Rocky Flats Plant, Blockson Chemical
Company, Area IV of the Santa Susana Field
Laboratory, Massachusetts Institute of
Technology (MIT), Texas City Chemicals;
Presentation by the Office of Compensation
Analysis and Support (OCAS) on special
science journal publication; a presentation on
Board interactions with Congressional
staffers; Department of Labor (DOL) Update;
Department of Energy (DOE) Update
including data access and security; Work
Group reports; Subcommittee on Dose
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Reconstruction Reviews Report; and Board
Future Plans and Schedules.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted
according to the policy provided below. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that
announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Christine Branche, PhD, Executive Secretary,
NIOSH, CDC, 395 E. Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513)
533–6800, Toll Free 1 (800) 35–NIOSH, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–13043 Filed 6–10–08; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 73, Number 113 (Wednesday, June 11, 2008)]
[Notices]
[Page 33094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13043]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Board Meeting Times and Dates (All times are Central Daylight
Time):
9 a.m.-5 p.m., June 24, 2008.
9 a.m.-5 p.m., June 25, 2008.
9 a.m.-2 p.m., June 26, 2008.
Public Comment Times and Dates (All times are Central Daylight
Time):
5 p.m.-6 p.m., June 24, 2008.
7:30 p.m.-8:30 p.m., June 25, 2008.
Place: Millennium Hotel St. Louis, 200 South 4th Street, St.
Louis, MO 63102, Telephone (314) 241-9500, Fax (314) 516-6149.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2009.
Purpose: This Advisory Board is charged with (a) providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters to be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Status Update; Special Exposure
Cohort (SEC) Petitions for: Y-12 Plant, Dow Chemical Company, and
Spencer Chemical Company; SEC Petition Updates: Chapman Valve, Rocky
Flats Plant, Blockson Chemical Company, Area IV of the Santa Susana
Field Laboratory, Massachusetts Institute of Technology (MIT), Texas
City Chemicals; Presentation by the Office of Compensation Analysis
and Support (OCAS) on special science journal publication; a
presentation on Board interactions with Congressional staffers;
Department of Labor (DOL) Update; Department of Energy (DOE) Update
including data access and security; Work Group reports; Subcommittee
on Dose Reconstruction Reviews Report; and Board Future Plans and
Schedules.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted according to the policy provided below. Any written
comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the
meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Christine Branche, PhD,
Executive Secretary, NIOSH, CDC, 395 E. Street, SW., Suite 9200,
Washington, DC 20201, Telephone (513) 533-6800, Toll Free 1 (800)
35-NIOSH, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-13043 Filed 6-10-08; 8:45 am]
BILLING CODE 4163-18-P
